Pharyngitis

Pharyngitis, colloquially known as throat inflammation or a sore throat, is a clinical condition characterized by the inflammation of the mucous membranes and lymphoid tissues of the oropharynx. It is not a discrete molecular target but a pathophysiological state resulting from various etiologies, including viral pathogens such as Rhinovirus or Adenovirus, bacterial infections like Streptococcus pyogenes (Group A Strep), or environmental irritants. The inflammatory process involves the recruitment of leukocytes and the release of chemical mediators such as bradykinin, prostaglandins, and interleukins, which sensitize local nociceptors and cause erythema and edema. Treatment strategies generally focus on symptom relief through the inhibition of cyclooxygenase (COX) enzymes or the use of antimicrobial agents to eradicate the underlying pathogen if bacterial. In the context of drug discovery, 'throat inflammation' represents a disease indication rather than a specific biological target, where therapeutic agents are directed at specific proteins or pathways involved in the inflammatory cascade.

Other names

Sore throatThroat inflammationInflammation of the pharynxTonsillitisLaryngitisAcute pharyngitis

Pharmacological management involves the inhibition of cyclooxygenase (COX-1/COX-2) to reduce prostaglandin E2 (PGE2) synthesis, the suppression of inflammatory cell migration via corticosteroid receptor agonism, local anesthesia through sodium channel blockade, and the inhibition of bacterial cell wall synthesis in the case of bacterial infection.